Muscle growth and anabolism in intensive care survivors (GAINS 2.0): Protocol for a multi-centre randomised; placebo controlled clinical trial of nandrolone in deconditioned adults recovering from critical illness.
<h4>Background</h4>Intensive care patients can experience significant long-term impairment in mobility and function caused by their critical illness. A potential contributory factor apart from critical illness polymyoneuropathy is the low levels of anabolic hormones in these patients. Te...
Saved in:
| Main Authors: | Matthew Anstey, Ed Litton, Maryam Habibi, Lisa Van der Lee, Robert Palmer, Natalie Tran, Bianca Mammana, Stacey Scheepers, Annamaria Palermo, Xavier Fiorilla, Bhaumik Mevavala, Adrian Regli, Angela Jacques, Bradley Wibrow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anabolic Steroid Use for Weight and Strength Gain in Critically Ill Patients: A Case Series and Review of the Literature
by: Matthew Anstey, et al.
Published: (2018-01-01) -
Towards a common definition of hospital-acquired deconditioning in adults: a scoping review
by: Katie Robinson, et al.
Published: (2025-01-01) -
Immediate and late effects of supraphysiological doses of nandrolone decanoate on the testis of rats
by: Bruno Felix-Patricio, et al.
Published: (2025-03-01) -
Exogenous Versus Endogenous Nandrolone in Doping Investigations: A Systematic Literature Review
by: Roberto Scendoni, et al.
Published: (2024-11-01) -
Nandrolone (17-Nortestosterone) And Glucose Metabolism: From Ugly Duckling To Handsome Swan
by: Sanjay Kalra, et al.
Published: (2025-03-01)